Mon, Jun 10 · 7:30

We will welcome over 300 delegates representing leading biotech companies, global pharmaceutical organisations and internationally renowned academic institutions.

Over 60+ presentations, case studies and panel discussions will focus on the key issues in drug discovery and medicinal chemistry.

4 Interactive Streams covering:

- Drug Discovery Innovation and Strategies
NEW FOR 2019! Focused Session: Protein Degradation In Drug Discovery and Drug Design

- Phenotypic Screening in Drug Discovery and High Content Screening Tools
NEW FOR 2019! Focused Session: AI and ML in Drug Discovery

- Biologics and Small Molecule Drug Target Discovery for Immuno-Therapy, Autoimmune Diseases and Oncology

- Innovation in Genome and Cell Based Drug Discovery, Screening, Imaging and Target Discovery



Registration Available from: EUR 390.0

Speakers: Ingo Hartung, Vice President of Medicinal Chemistry, Bayer, Michael Didriksen, Senior Director, Lundbeck, Rob Howes, Director, Reagents and Assay Development, Discovery Sciences, AstraZeneca, Anil Vasudevan, Director, Discovery Chemistry and Technology, AbbVie, Lauren Drowley , Director, Functional Genomics Lead, UCB Pharma, Davide Gianni, Associate Director, AstraZeneca, Alex Batchelor, Chief Executive Officer, Orbit Discovery